A comparison of iCare and Goldmann applanation tonometry measurements during the COVID-19 pandemic: a retrospective study
- PMID: 38910200
- PMCID: PMC11194190
- DOI: 10.1007/s10792-024-03220-8
A comparison of iCare and Goldmann applanation tonometry measurements during the COVID-19 pandemic: a retrospective study
Abstract
Purpose: To evaluate factors associated with differences in intraocular pressure (IOP) readings between iCare and Goldmann applanation tonometry (GAT) in established glaucoma patients.
Methods: This retrospective comparative study included clinical data of 350 eyes from 350 established glaucoma patients who had iCare and GAT IOP measured by an ophthalmic technician and a glaucoma specialist, respectively. The main outcome measure was the difference in IOP measurements of the right eyes with iCare and GAT.
Results: The intraclass correlation coefficient (ICC) between GAT and iCare was 0.90. The mean IOP difference between tonometers was - 0.18 ± 2.89 mmHg. Bland-Altman plots indicated a 95% limit of agreement of - 5.8 to 5.5 mmHg. Central corneal thickness (CCT) and age were significantly correlated with the difference in IOPs of the iCare and GAT. GAT-IOP and age were significantly associated with the absolute difference in measured IOP of the two tonometers. The difference in measurements was not significantly associated with prior glaucoma surgery, average global index of optical coherence tomography, axial length, technician years of experience and certification, and IOP range.
Conclusion: Although there is good agreement between the iCare and GAT mean values, these devices are not interchangeable in glaucoma patients due to the wide range of the limit of agreement.
Keywords: Glaucoma; Goldmann applanation tonometry; Intraocular pressure; iCare.
© 2024. The Author(s).
Conflict of interest statement
SS (Swaminathan), AK (Kisielewski), and MHN (Nowroozzadeh) have no disclosures; SH (Hallaj) is supported by the National Institute of Health, Bridge to AI common fund (grant number: OT2OD032644); DL (Lee): Consultant: Allergan, Inc. Research: Allergan, Inc. Speaker: Glaukos Corp; NK (Kolomeyer): Research: Guardion Health Sciences Inc, Consultant/Research: Allergan/AbbVie, Consultant: Alimera, Consultant: Regeneron, Consultant/Speaker: Bioge, Consultant/Speaker: Genentech, Consultant/Speaker: Iveric, Consultant: Vial; JSM (Myers): Consultant: Avisi, Olleyes; Research: AbbVie, Elios, Equinox, Glaukos, Guardian, Laboratories Thea, Nicox, Olleyes, Santen; RR (Razeghinejad): Equinox, Olleyes.
Figures
References
-
- Brusini P, Salvetat ML, Zeppieri M et al (2006) Comparison of ICare tonometer with Goldmann applanation tonometer in glaucoma patients. J Glaucoma 15:213–217. 10.1097/01.ijg.0000212208.87523.66 - PubMed
-
- Pakrou N, Gray T, Mills R et al (2008) Clinical comparison of the Icare tonometer and Goldmann applanation tonometry. J Glaucoma 17:43–47. 10.1097/IJG.0b013e318133fb32 - PubMed
-
- Asrani S, Chatterjee A, Wallace DK et al (2011) Evaluation of the ICare rebound tonometer as a home intraocular pressure monitoring device. J Glaucoma 20:74–79. 10.1097/IJG.0b013e3181d78811 - PubMed
-
- Briesen S, Schulze Schwering M, Roberts H et al (2010) Minimal cross-infection risk through Icare rebound tonometer probes: a useful tool for IOP-screenings in developing countries. Eye 24:1279–1283. 10.1038/eye.2009.297 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Medical